Lilly, AstraZeneca, Sanofi Sue HHS Over 340B Contract Pharmacy Opinion

By Michelle M. Stein / January 13, 2021 at 9:37 PM
Drug makers Eli Lilly, Sanofi and AstraZeneca sued HHS over its general counsel advisory opinion that says drug manufacturers are required to provide 340B discounts to providers in the program via contract pharmacies, with two of the drug makers stating the advisory opinion, if allowed to stand, would doom any administrative disputes over contract pharmacy restrictions. An administrative dispute request came in Wednesday (Jan. 13), the day HHS’ ADR rule went into effect. The HHS Office of General Counsel issued...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.